Argatroban

Overview

4.5 out of 5 (45 Reviews)

Credits

1.00

Post Assessment Questions

5

Start Date

1 Sep 2023

Last Review Date

1 Sep 2023

Expiration Date

31 Aug 2026

Estimated Time To Finish

60 Minutes


 
Need Help?  If you have a system or content concerns, please contact support@statpearls.com

Activity Description

Argatroban is a medication used to manage heparin-induced thrombocytopenia (HIT), which is a rare, life-threatening complication of heparin therapy. It is a direct thrombin inhibitor, a class of anticoagulant drugs. This activity outlines the indications, action, and contraindications for argatroban as a valuable agent in the prophylaxis and treating thrombosis in patients with HIT. This activity also highlights the mechanism of action, adverse event profile, and other key factors (e.g., off-label uses, dosing, pharmacodynamics, pharmacokinetics, monitoring, relevant interactions) pertinent for members of the healthcare team in the management of patients with heparin-induced thrombocytopenia.


XXXXX

 

 

 

UAN: JA4008338-0000-23-5482-H01-P

Target Audience

This activity has been designed to meet the educational needs of physicians, physician associates, nurses, pharmacists, and nurse practitioners.

Learning Objectives

At the conclusion of this activity, the learner will be better able to:

  • Identify the mechanism of action of argatroban.
  • Describe the potential adverse effects of argatroban.
  • Review the appropriate monitoring for patients on argatroban.
  • Discuss interprofessional team strategies for improving care coordination and communication to advance argatroban and improve outcomes.

Pharmacy Activity Type:
Disease/Drug Therapy Related


Disclosures

StatPearls, LLC requires everyone who influences the content of an educational activity to disclose relevant financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant conflict(s) of interest have been mitigated. Hover over contributor names for financial disclosures. Others involved in planning this educational activity have no relevant financial relationships to disclose.

Commercial Support: This activity has received NO commercial support.

Continuing Education Accreditation Information

In support of improving patient care, StatPearls, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

 

Pharmacists: StatPearls, LLC designates this activity for a maximum of 1.00 ACPE credit(s). (UAN: JA4008338-0000-23-5482-H01-P ). Pharmacists should only claim credit commensurate with the extent of their participation in the activity.

Please consult your professional licensing board for information on the applicability and acceptance of continuing education credit for this activity.

Method of Participation and Credit

  1. Register for the activity.    
  2. Review the target audience, learning objectives, and disclosure information.
  3. Study the educational content of the enduring material.
  4. Choose the best answer to each activity test question. To receive credit and a certificate, you must pass the test questions with a minimum score of 100%.
  5. Complete the post-activity assessment survey.

If you have concerns regarding the CE/CME system, please contact support@statpearls.com.

Disclaimer

This educational activity was planned and produced in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. Faculty may discuss investigational products or off-label uses of products regulated by the FDA. Readers should verify all information before employing any therapies described in this educational activity.

The information provided for this activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The information presented does not necessarily reflect the views of StatPearls or any commercial supporters of educational activities on statpearls.com. StatPearls expressly disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through a participant's misunderstanding of the content.

Unapproved Uses of Drugs/Devices: In accordance with FDA requirements, the audience is advised that information presented in this continuing education activity may contain references to unlabeled or unapproved uses of drugs or devices. Please refer to the FDA-approved package insert for each drug/device for full prescribing/utilization information.

Cancellation Policy: Please see the cancellation policy. StatPearls, LLC reserves the right to cancel any course due to unforeseen circumstances.

 

 
 

Reviews

Deborah Z. on 3/16/2021

Jason H. on 5/26/2021

Lisa R. on 10/14/2021

Christopher W. on 10/10/2021

Kathleen H. on 3/4/2022

Peter S. on 4/4/2022

Emmy K. on 4/7/2022

Hardeep A. on 9/27/2022

Kimber E. on 10/15/2022

Philip P. on 12/2/2022

Amr K. on 12/5/2022

Ashley S. on 12/10/2022

Melanie S. on 1/4/2023

Alexander D. on 3/26/2023

Maureen W. on 6/4/2023

Ginger M. on 8/12/2023

Allynda H. on 8/29/2023

Sean O. on 8/31/2023

William T. on 9/3/2023

Charlie C. on 9/6/2023

S s. on 9/19/2023

Douglas P. on 9/22/2023

David L. on 9/28/2023

Kevin B. on 9/28/2023

JOSEPH B. on 10/2/2023

Nikhil K. on 10/2/2023

chris w. on 10/3/2023

George D. on 10/7/2023

pushpinder s. on 10/15/2023

Rachael S. on 10/15/2023

Danial K. on 10/18/2023

Mark P. on 10/24/2023

Richard C. on 11/3/2023

Sandy M. on 11/27/2023

Jeffrey B. on 12/3/2023

Nicole Q. on 12/3/2023

richard m. on 12/9/2023

Omar M. on 12/13/2023

Nitin M. on 12/31/2023

Trevor D. on 12/30/2023

Belmari R. on 1/5/2024

Brian B. on 1/20/2024

CAROL G. on 1/25/2024

Gretchen M. on 4/3/2024

Mary K. on 4/12/2024

Unlimited Pharmacist CE

Stay up to date on the latest medical knowledge with 6673 CE activities. In these online self-assessment activities, read our reference articles and test your knowledge with more than 7924.5 hours of CE.

Single Activity

Take this single activity

$29 1 activity

6 Month Unlimited Pharmacist CE

Access to all the Unlimited Pharmacist CE activities in all specialties.

$119 per half year per user

1 Year Unlimited Pharmacist CE

Access to all the Unlimited Pharmacist CE activities in all specialties.

$199 per 1 year per user